Genzyme, Sanofi Mum On Merger Negotiations At JPM Conference

Genzyme depicts itself as the picture of health with enzyme replacement therapy business returning to normal after manufacturing woes.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet